Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Products Under Development 2025 services provided by Dr. Reddy's Laboratories

Dr. Reddy's Laboratories
Products Under Development 2025

PDF Upload May, 2025

Dr. Reddy’s Q4 & full year FY25 Financial Results

10 May 2025

// PRESS RELEASE

Dr Reddy's to introduce Sanofi's novel drug in India

29 Apr 2025

// PRESS RELEASE

Sanofi puts insulin brand Lantus up for sale, eyes Rs 2,000 cr

15 Apr 2025

// ECONOMICTIMES

DATA COMPILATION
#PharmaFlow

DRL VB RM

Contact Supplier

CPhI North America

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.pharmacompass.com/video-pharmareel/dr-reddys-laboratories/leading-supplier-of-apis-for-40-years

Xls

CATEGORY PAGE

Dr. Reddy's Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2025, Corporate Presentation, API Product List 2025, Products Under Development 2025, FDF Product List 2024, GMP Certificate 2024

Product List 2025
Corporate Presentation
API Product List 2025
Products Under Development 2025
FDF Product List 2024
GMP Certificate 2024

VIDEO(s)

Leading Supplier of APIs for 40+ Years, Your Partner for High-Quality & Cost-effective APIs, Dr. Reddy's - About Us

Leading Supplier of APIs for 40+ Years
Your Partner for High-Quality & Cost-effective APIs
Dr. Reddy's - About Us

DIGITAL CONTENT

2 Vlog #PharmaReel, 9 Corporate Content #SupplierSpotlight, 8 Data Compilation #PharmaFlow, 1094 News #PharmaBuzz

2 Vlog #PharmaReel
9 Corporate Content #SupplierSpotlight
8 Data Compilation #PharmaFlow
1094 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

275 All APIs, 154 USDMF, 46 CEP/COS, 32 JDMF, 105 EU WC, 147 KDMF, 114 NDC API, 146 Listed APIs

275 All APIs
154 USDMF
46 CEP/COS
32 JDMF
105 EU WC
147 KDMF
114 NDC API
146 Listed APIs

DEVELOPMENTS

106 Drugs in Development

106 Drugs in Development

FINISHED DOSAGE FORMULATIONS

818 FDF Dossiers, 585 FDA Orange Book, 10 Europe, 223 Listed Dossiers

818 FDF Dossiers
585 FDA Orange Book
10 Europe
223 Listed Dossiers

KEY PRODUCTS

Apixaban, Capecitabine, Carfilzomib, Dabigatran Etexilate Mesylate, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Empagliflozin, Enzalutamide, Eribulin, Ferric Carboxymaltose, Glatiramer Acetate, Iron Sucrose, Mirabegron, Nilotinib, Olaparib, Palbociclib, Quetiapine Hemifumarate, Rivaroxaban, Sacubitril-Valsartan, Sitagliptin Hydrochloride, Sitagliptin Malate, Sitagliptin Phosphate, Sugammadex Sodium

Apixaban
Capecitabine
Carfilzomib
Dabigatran Etexilate Mesylate
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Empagliflozin
Enzalutamide
Eribulin
Ferric Carboxymaltose
Glatiramer Acetate
Iron Sucrose
Mirabegron
Nilotinib
Olaparib
Palbociclib
Quetiapine Hemifumarate
Rivaroxaban
Sacubitril-Valsartan
Sitagliptin Hydrochloride
Sitagliptin Malate
Sitagliptin Phosphate
Sugammadex Sodium

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

66 FDA, 37 EDQM, 18 GDUFA

66 FDA
37 EDQM
18 GDUFA

PC100302

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!